OsteoPreP: Food Supplements for Postmenopausal Bone Health

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

March 28, 2024

Study Completion Date

April 30, 2025

Conditions
Postmenopausal OsteopeniaBone Loss, Age RelatedAge-Related SarcopeniaGlucose Metabolism DisordersAge-related Cognitive Decline
Interventions
DIETARY_SUPPLEMENT

Pendulum WBF-038

"All bacteria contained in Pendulum WBF-038 are commensal organisms that have been repeatedly documented to inhabit the human gastrointestinal tract under normal circumstances. Pendulum's WBF-038 is a proprietary formulation of the following strains: Akkermansia muciniphila, Clostridium butyricum, Clostridium beijerinckii, Anaerobutyricum hallii, Bifidobacterium infantis, plus chicory inulin and magnesium stearate. The organisms were grown under controlled conditions consistent with Good Manufacturing Practices (GMP) and employ no animal-derived products. All ingredients utilized during manufacturing were food grade and qualified as generally recognized as safe (GRAS).~The product is provided as acid-resistant capsules in bottles that are to be stored refrigerated at 4℃."

DIETARY_SUPPLEMENT

Pendulum Placebo

Pendulum placebo capsules containing magnesium stearate

Trial Locations (1)

3000

Australian Catholic University, Melbourne

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pendulum Therapeutics

INDUSTRY

collaborator

Curtin University

OTHER

lead

Australian Catholic University

OTHER

NCT05348694 - OsteoPreP: Food Supplements for Postmenopausal Bone Health | Biotech Hunter | Biotech Hunter